Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-008066

Options or other derivatives

  • Executive Vice President acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Holsinger Leslie Executive Vice President 2020-02-06 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…